SCHEMBL31715259

SCHEMBL31715259

O=c1c2cc(O)c(-c3cnco3)cc2ncn1Cc1ccc(Cl)cc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SCD O00767 4/20 0.48
▸ PDE5A O76074 1/20 0.46
▸ HDAC6 Q9UBN7 2/20 0.46
▸ MMP13 P45452 1/20 0.45
▸ TP53 P04637 1/20 0.41
▸ HDAC3 O15379 1/20 0.40
▸ HDAC4 P56524 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC7 Q8WUI4 1/20 0.40
▸ HDAC2 Q92769 1/20 0.40
▸ HDAC10 Q969S8 1/20 0.40
▸ HDAC11 Q96DB2 1/20 0.40
▸ HDAC8 Q9BY41 1/20 0.40
▸ HDAC9 Q9UKV0 1/20 0.40
▸ HDAC5 Q9UQL6 1/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ GRK2 P25098 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31715291 0.86 HDAC6 (0.51) SCDPDE5AHDAC6HDAC3HDAC4
SCHEMBL31715284 0.83 PDE5A (0.53) SCDPDE5AHDAC6MMP13TP53
SCHEMBL31715261 0.81 PDE5A (0.39) SCDPDE5AHDAC6MMP13HDAC3
SCHEMBL23555570 0.75 PDE5A (0.38) SCDPDE5AHDAC6MMP13TP53
SCHEMBL31715265 0.75 PDE5A (0.38) SCDPDE5AHDAC6MMP13TP53
SCHEMBL31715277 0.74 PDE5A (0.37) SCDPDE5AHDAC6MMP13TP53
SCHEMBL31715278 0.73 PDE5A (0.36) SCDPDE5AHDAC6MMP13TP53
SCHEMBL4531658 0.71 GRK2 (0.60) SCDMMP13GRK2
SCHEMBL23555557 0.69 TP53 (0.62) SCDPDE5AHDAC6MMP13TP53
SCHEMBL2318321 0.69 SCD (0.61) SCDPDE5AHDAC6MMP13TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025227148-A1 BICYCLIC HETEROCYCLE COMPOUNDS FOR TREATMENT OF HERPES VIRUSES ASSEMBLY BIOSCIENCES, INC. (US) 2025-10-30 — — WO disclosed
Send feedback